← Back to Patent Explorer
US4532241A Expired / Lapsed US ⏱️ 0.0 years remaining

8,10-Dideazaminopterins

Assignee: SRI International Inc
•
Filing: 1984-01-17
•
Granted: 1985-07-30
•
Expires: 2004-01-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 10-Alkyl-8,10-dideazaminopterins of the formula ##STR1## where R is hydrogen or alkyl of 1 to about 8 carbon and their carboxylate and acid addition salts are described. These compounds exhibit antineoplastic activity that is similar to, but more effective than, methotrexate.

Inventors

  • 👤 Joseph I. DeGraw
  • 👤 Lawrence F. Kelly
  • 👤 Francis M. Sirotnak

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 00:18
CPC Classifications
C; C07; C07D; C07D471/00; C07D471/02; C07D471/04

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 1 words
10-Ethyl-8,10-dideazaminopterin.
Claim 2
Dependent Claim 1 words
10-Ethyl-8,10-dideazaminopterin.
Claim 3
Dependent Claim 20 words
An antineoplastic composition comprising a therapeutically effective amount of 10-ethyl-8,10-dideazaminopterin or a salt thereof combined with a pharmaceutically acceptable carrier.
Claim 4
Dependent Claim 20 words
An antineoplastic composition comprising a therapeutically effective amount of 10-ethyl-8,10-dideazaminopterin or a salt thereof combined with a pharmaceutically acceptable carrier.
Claim 5
Independent Claim 24 words
A method of inhibiting neoplastic growth in a living animal comprising administering a therapeutically effective amount of 10-ethyl-8,10-dideazaminopterin or a pharmaceutically acceptable salt thereof.
Claim 6
Independent Claim 24 words
A method of inhibiting neoplastic growth in a living animal comprising administering a therapeutically effective amount of 10-ethyl-8,10-dideazaminopterin or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

US4460591A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-07-29 1989-01-28 1989-07-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-07-29 1993-01-28 1993-07-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-07-29 1997-01-28 1997-07-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag